A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
Phase 1
- Conditions
- non small cell lung cancer
- Registration Number
- JPRN-UMIN000013223
- Lead Sponsor
- Kochi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with active lung disease such as interstitial pneumonia, pneumoconiosis, radiation pneumonitis, or drug-induced lung damage 2) complicated by infectious disease requiring intravenous administration of antifungal agents and/or antibacterial agents 3) active double cancer 4) Patients with problematic complication(s) (ex. uncontrol heart disease, serious arrhythmia) 5) pregnant or lactating women or those who declined contraception 6) Patients with severe mental illness 7) Unsuitable patients judged by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimation of the recommended dose, evaluation of dose-limiting toxicity
- Secondary Outcome Measures
Name Time Method safety and efficacy